Join to View Full Profile
110 Rehill AveSomerville, NJ 08876
Phone+1 908-685-2200
Dr. Johnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Matthew Johnson is a psychiatrist based in NJ, currently licensed in NJ and CT. He completed his residency at Yale University/Yale-New Haven Hospital. Currently, he serves as a Medical Director at Robert Wood Johnson University Hospital Somerset, and owner of his private practice, Encompass Psychiatry. His expertise includes general psychiatry, eating disorders, addiction medicine/psychiatry, medical business, consulting, health law, and veteran care. Dr. Johnson has published several articles in reputable journals such as The American Journal on Addictions and Journal of Affective Disorders, and has received the Resident Teaching Award from Yale University.
Education & Training
Yale-New Haven Medical CenterChief Residency, Psychiatry, 2023 - 2024
Jersey Shore University Medical CenterResidency, Psychiatry, 2020 - 2023
Rowan University School of Osteopathic MedicineClass of 2020
Certifications & Licensure
CT State License 2023 - 2026
NJ State License 2024 - 2025
Awards, Honors, & Recognition
- Resident Teaching Award Yale University, 2023-2024
Publications & Presentations
PubMed
- A detox dilemma beyond benzodiazepines; clonidine's quandary in alcohol withdrawal management.Matthew Johnson, Danielle Cosentino, Brian Fuehrlein
The American Journal on Addictions. 2025-01-01 - 25 citationsMental health symptom severity in cannabis using and non-using Veterans with probable PTSDMatthew J. Johnson, John D. Pierce, Shahrzad Mavandadi, Johanna Klaus, Diana Defelice
Journal of Affective Disorders. 2016-01-15
Journal Articles
- Now I know my CBDs; cases of psychiatric admissions after delta-8-tetrahydrocannabinol (Delta-8-THC, Δ⁸-THC) product usageJohnson MJ, Swenson C, Fishkin I, Malanga A, Psychiatry Research Case Reports, 8/20/2023
- QT and the beast: a case of valproate monotherapy for schizoaffective disorder-bipolar type with comorbid congenital long QT syndromeMatthew J Johnson, Michael Kelson, Heemani Ruparel, Ka-Lisha Simons, Philip Vincent, Psychiatry Research Case Reports, 10/25/2022
- Atypical presentation of STEMI with pericardial effusion causing cardiac tamponade related to malignancyJohnson MJ, Penmetcha R, The British Journal of Cardiology, 10/17/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
